Tumor Infiltrating Lymphocytes and Response To Neoadjuvant Chemotherapy in Invasive Breast Cancer

被引:0
|
作者
Fineberg, Susan [1 ]
McLemore, Lauren [1 ]
机构
[1] Montefiore Med Ctr, Bronx, NY 10467 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
167
引用
收藏
页码:45A / 45A
页数:1
相关论文
共 50 条
  • [31] PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer
    Wimberly, Hallie
    Brown, Jason R.
    Schalper, Kurt
    Haack, Herbert
    Silver, Matthew R.
    Nixon, Christian
    Bossuyt, Veerle
    Pusztai, Lajos
    Lannin, Donald R.
    Rimm, David L.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2015, 3 (04) : 326 - 332
  • [32] The Value of Tumor Infiltrating Lymphocytes (TIL) for Predicting the Response to Neoadjuvant Chemotherapy (NAC) in Breast Cancer according to the Molecular Subtypes
    Faur, Ionut Flaviu
    Dobrescu, Amadeus
    Clim, Adelina Ioana
    Pasca, Paul
    Prodan-Barbulescu, Catalin
    Gherle, Bogdan Daniel
    Tarta, Cristi
    Isaic, Alexandru
    Brebu, Dan
    Duta, Ciprian
    Totolici, Bogdan
    Lazar, Gabriel
    Elble, Randolph C.
    [J]. BIOMEDICINES, 2023, 11 (11)
  • [33] The Value of Tumor Infiltrating Lymphocytes (TILs) for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis
    Mao, Yan
    Qu, Qing
    Zhang, Yuzi
    Liu, Junjun
    Chen, Xiaosong
    Shen, Kunwei
    [J]. PLOS ONE, 2014, 9 (12):
  • [34] Association of tumor-infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancer
    Hong, Jin
    Rui, Weiwei
    Fei, Xiaochun
    Chen, Xiaosong
    Shen, Kunwei
    [J]. CANCER MEDICINE, 2021, 10 (22): : 7921 - 7933
  • [35] Predictive and prognostic value of tumor-infiltrating lymphocytes in breast cancer treated with neoadjuvant chemotherapy.
    Matsumoto, Akiko
    Jinno, Hiromitsu
    Hiraiwa, Kunihiko
    Nakamura, Tetsuya
    Saito, Junichi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [36] Pathological response and tumor-infiltrating-lymphocytes post neoadjuvant chemotherapy.
    Roque, Katia Mercedes
    Nino, Marco Galvez
    Castaneda Altamirano, Carlos Arturo
    Garcia, Miluska Castillo
    Sanchez, Joselyn
    Bernabe, Luis A.
    Fuentes, Hugo Alejandro
    Sandival, Gustavo
    Cotrina, Jose M.
    Dunstan, Jorge Antonio
    Abugattas, Julio
    Mantilla, Raul
    De La Cruz, Miguel
    Gomez, Henry Leonidas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer
    Koenig, Lisa
    Mairinger, Fabian D.
    Hoffmann, Oliver
    Bittner, Ann-Kathrin
    Schmid, Kurt W.
    Kimmig, Rainer
    Kasimir-Bauer, Sabine
    Bankfalvi, Agnes
    [J]. BMC CANCER, 2019, 19 (1)
  • [38] Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer
    Lisa König
    Fabian D. Mairinger
    Oliver Hoffmann
    Ann-Kathrin Bittner
    Kurt W. Schmid
    Rainer Kimmig
    Sabine Kasimir-Bauer
    Agnes Bankfalvi
    [J]. BMC Cancer, 19
  • [39] Tumor-Associated Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
    Lee, Hee Jin
    Seo, Jin-Young
    Ahn, Jin-Hee
    Ahn, Sei-Hyun
    Gong, Gyungyub
    [J]. JOURNAL OF BREAST CANCER, 2013, 16 (01) : 32 - 39
  • [40] Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
    Denkert, Carsten
    Loibl, Sibylle
    Noske, Aurelia
    Roller, Marc
    Mueller, Berit Maria
    Komor, Martina
    Budczies, Jan
    Darb-Esfahani, Silvia
    Kronenwett, Ralf
    Hanusch, Claus
    von Toerne, Christian
    Weichert, Wilko
    Engels, Knut
    Solbach, Christine
    Schrader, Iris
    Dietel, Manfred
    von Minckwitz, Gunter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) : 105 - 113